Search
for
Sort by
Research 271–300 of 1000+
- La combinación de finasteride y doxazosina fue más efectiva que la monoterapia en la hiperplasia prostática benigna
- The prognostic value of androgenetic alopecia and benign prostatic hyperplasia in men with COVID-19: a prospective multidisciplinaryobservational study of 766 patients from Turkey
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Association of Androgenetic Alopecia with Benign Prostatic Hyperplasia: A Case Control Study
- Comparación del efecto terapéutico entre el extracto etanólico del fruto de Physalis peruviana, Finasteride y Terazosine en la hiperplasia prostática benigna inducida en ratas
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia
- 409 ANDROGEN RECEPTOR GENE POLYMORPHISM (SNP RS6152) – ITS RELATIONSHIP TO ANDROGEN-SENSITIVE GENES EXPRESSION IN BENIGN PROSTATIC HYPERPLASIA, CARCINOMA OF THE PROSTATE AND ANDROGENETIC ALOPECIA
- Cutaneous, Cranial, and Skeletal Defects in Children and Adults with Focal Dermal Hypoplasia
- 190 A cross-sectional study evaluating skin, hair, nail and bone disease in patients with focal dermal hypoplasia
- 1465 Optimization/characterization of a Focal Dermal Hypoplasia mouse model to test potential treatments
- Emergence of hereditary hyperplastic gingivitis in Newfoundland and Labrador, Canada: an exploration into the molecular aetiology at both the gene and genome levels
- A case report of a novel homozygote mutation causing severe Leydig cell hypoplasia: insights in the coexistence of nonsense mutation and polymorphism in the same LHCGR gene locus
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
- Endocrine control of benign prostatic hyperplasia
- The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
- Abstract 1835: Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3 (WHSC1L1)
- Medical management of benign prostatic hyperplasia
- Medico-Surgical Therapeutic Management of Benign Prostatic Hyperplasia
- Update on medical management of benign prostatic hyperplasia
- A case of finasteride-induced hyperplasia of mammary glands
- Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFα expression in transgenic mice
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia